Company name
Distribuidora Farmacéutica Ecuatoriana Difare S.A.
Project number
14944-01
Category B projects have potential environmental and/or social impacts and risks that are less adverse than those of a Category A and which are generally limited to the project site, largely reversible and can be mitigated via measures that are readily available and feasible to implement in the context of the operation.
E&S category
B
Country
![](https://idbinvest.org/sites/default/files/styles/size54x40/public/2018-03/Ecuador.png?itok=vgC2rRSa)
Ecuador
Sector
![](https://idbinvest.org/sites/default/files/styles/size38x28/public/2021-02/MANUFACTURING%20Iconography_1_Manufacturing_icon.png?itok=uhosFnB8)
Manufacturing
Status
Proposed
Disclosed date
08/30/2024
Projected date at which a project will be put forward for the Board of Executive Directors’ approval.
Projected board date
09/30/2024
Approval date
N/A
Signed date
N/A
Sponsoring entity
N/A
Investment Operations Department Contact
Corporates Division
Investment type
Syndicated amount
N/A
Financing amount
USD $ 35,000,000
Currency
USD
Project scope and objective
La presente operación (el “Proyecto”) consiste en la suscripción por parte de BID Invest de un Bono Vinculado a la Sostenibilidad (“SLB”, por sus siglas en inglés) emitido por Distribuidora Farmacéutica Ecuatoriana S.A. (“Difare”), por hasta US$35 millones, a un plazo de hasta cinco años, y la movilización de recursos para completar el costo total del proyecto que asciende a US$50 millones. Difare utilizará los recursos del Bono para financiar actividades corporativas generales, incluyendo capital de trabajo permanente e inversiones en Capex, con el objetivo de seguir ampliando su red de farmacias en el país.
Difare es una empresa ecuatoriana que se dedica a la distribución, comercialización y venta minorista de productos farmacéuticos, y forma parte del conglomerado de nueve empresas ecuatorianas del Grupo Difare. La empresa inició sus operaciones hace 40 años y actualmente cuenta con más de 5,000 empleados y atiende como distribuidor a más de 10,000 puntos de venta que cubren minoristas, mayoristas, farmacias, y centros de salud públicos y privados. La empresa es propietaria de marcas como Farmacias Cruz Azul, Farmacias Comunitarias y Pharmacy's.
For inquiries, comments and information requests about the project
Request informationLearn more about how we provide private-sector solutions in the region .
Contact information
For inquiries, comments and information requests about the project
Request informationAlternatively, you may also use the following contact information :
Client Contact
info@grupodifare.com
PHONE NUMBER
n.a
POST OFFICE ADDRESS
IDB Invest Contact
requestinformation@idbinvest.org
PHONE
+1(202)-566-4566
ADDRESS
1350 New York Ave NW, Washington, DC 20005
COUNTRY OFFICES
IDB Invest Country OfficesFor inquiries, comments and information requests about the project
Request informationLearn more about how we provide private-sector solutions in the region .
Environmental and social review
IDB Invest conducts an environmental and social due diligence (ESDD) commensurate with the nature, scale, and stage of the project, and with its level of environmental and social risks and impacts. The ESDD will confirm the project E&S categorization and assess the project with respect to the client requirements in IDB Invest Environmental and Social Sustainability Policy. The results of the ESDD, including any identified gaps are described in the Environmental and Social Review Summary (ESRS) provided below. For projects approved as of 2016, any gaps with respect to IDB Invest's Environmental and Social Sustainability Policy at the time of the ESDD are addressed in the Environmental and Social Action Plan (ESAP) presented below, to comply with the date mentioned above.
DIFARE - RESUMEN DE LA REVISIÓN AMBIENTAL Y SOCIAL (RRAS)
481.3 Kb
DIFARE - PLAN DE ACCIÓN AMBIENTAL Y SOCIAL (PAAS O ESAP)
266.2 Kb